Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 4
2005 2
2006 6
2007 1
2008 1
2009 2
2010 2
2011 1
2012 2
2013 2
2014 2
2015 3
2016 4
2017 2
2018 5
2019 1
2020 1
2021 3
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Radiation and Anti-Cancer Vaccines: A Winning Combination.
Cadena A, Cushman TR, Anderson C, Barsoumian HB, Welsh JW, Cortez MA. Cadena A, et al. Among authors: anderson c. Vaccines (Basel). 2018 Jan 30;6(1):9. doi: 10.3390/vaccines6010009. Vaccines (Basel). 2018. PMID: 29385680 Free PMC article. Review.
There's been a Flaw in Our Thinking.
Anderson CL. Anderson CL. Front Immunol. 2014 Oct 31;5:540. doi: 10.3389/fimmu.2014.00540. eCollection 2014. Front Immunol. 2014. PMID: 25400634 Free PMC article. Review. No abstract available.
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?
Aliru ML, Schoenhals JE, Venkatesulu BP, Anderson CC, Barsoumian HB, Younes AI, K Mahadevan LS, Soeung M, Aziz KE, Welsh JW, Krishnan S. Aliru ML, et al. Among authors: anderson cc. Immunotherapy. 2018 Feb 1;10(4):299-316. doi: 10.2217/imt-2017-0082. Immunotherapy. 2018. PMID: 29421979 Free PMC article. Review.
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab.
Fukuoka S, Koga Y, Yamauchi M, Koganemaru S, Yasunaga M, Shitara K, Doi T, Yoshino T, Kuronita T, Elenbaas B, Wahra P, Zhang H, Crowley L, Jenkins MH, Clark A, Kojima T. Fukuoka S, et al. Among authors: clark a. Sci Rep. 2023 Sep 25;13(1):16017. doi: 10.1038/s41598-023-40612-9. Sci Rep. 2023. PMID: 37749105 Free PMC article.
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies.
Goodstal SM, Lin J, Crandall T, Crowley L, Bender AT, Pereira A, Soloviev M, Wesolowski JS, Iadevaia R, Schelhorn SE, Ross E, Morandi F, Ma J, Clark A. Goodstal SM, et al. Among authors: clark a. Sci Rep. 2023 Nov 21;13(1):20412. doi: 10.1038/s41598-023-47735-z. Sci Rep. 2023. PMID: 37989777 Free PMC article.
Network Localization of Unconscious Visual Perception in Blindsight.
Kletenik I, Ferguson MA, Bateman JR, Cohen AL, Lin C, Tetreault A, Pelak VS, Anderson CA, Prasad S, Darby RR, Fox MD. Kletenik I, et al. Among authors: anderson ca. Ann Neurol. 2022 Feb;91(2):217-224. doi: 10.1002/ana.26292. Epub 2022 Jan 10. Ann Neurol. 2022. PMID: 34961965 Free PMC article.
Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors.
Xiao Y, Huck BR, Lan R, DeSelm L, Chen X, Qiu H, Neagu C, Johnson T, Mochalkin I, Gardberg A, Jiang X, Tian H, Dutt V, Santos D, Head J, Jackson J, Syed S, Lin J, Wilker E, Ma J, Clark A, Machl A, Bankston D, Jones CCV, Goutopoulos A, Sherer B. Xiao Y, et al. Among authors: clark a. Bioorg Med Chem Lett. 2021 Oct 15;50:128352. doi: 10.1016/j.bmcl.2021.128352. Epub 2021 Sep 2. Bioorg Med Chem Lett. 2021. PMID: 34481987
51 results